570 related articles for article (PubMed ID: 23344851)
1. Urinary exosomes and diabetic nephropathy: a proteomic approach.
Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
[TBL] [Abstract][Full Text] [Related]
2. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
[TBL] [Abstract][Full Text] [Related]
3. Differential protein profiling of renal cell carcinoma urinary exosomes.
Raimondo F; Morosi L; Corbetta S; Chinello C; Brambilla P; Della Mina P; Villa A; Albo G; Battaglia C; Bosari S; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1220-33. PubMed ID: 23511837
[TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
7. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
Togashi Y; Miyamoto Y
Exp Toxicol Pathol; 2013 Jul; 65(5):615-22. PubMed ID: 22795897
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
[TBL] [Abstract][Full Text] [Related]
9. Urinary exosomes and proteomics.
Moon PG; You S; Lee JE; Hwang D; Baek MC
Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
[TBL] [Abstract][Full Text] [Related]
10. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
11. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease.
Mishra DD; Sahoo B; Maurya PK; Sharma R; Varughese S; Prasad N; Tiwari S
Front Endocrinol (Lausanne); 2023; 14():1157194. PubMed ID: 37251672
[TBL] [Abstract][Full Text] [Related]
13. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer.
Tsai YC; Kuo MC; Hung WW; Wu PH; Chang WA; Wu LY; Lee SC; Hsu YL
Cell Commun Signal; 2023 Jan; 21(1):10. PubMed ID: 36639674
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma.
Kalra H; Adda CG; Liem M; Ang CS; Mechler A; Simpson RJ; Hulett MD; Mathivanan S
Proteomics; 2013 Nov; 13(22):3354-64. PubMed ID: 24115447
[TBL] [Abstract][Full Text] [Related]
15. A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes.
Del Boccio P; Raimondo F; Pieragostino D; Morosi L; Cozzi G; Sacchetta P; Magni F; Pitto M; Urbani A
Electrophoresis; 2012 Feb; 33(4):689-96. PubMed ID: 22451062
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
[TBL] [Abstract][Full Text] [Related]
17. A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
Raj DA; Fiume I; Capasso G; Pocsfalvi G
Kidney Int; 2012 Jun; 81(12):1263-72. PubMed ID: 22418980
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of low-abundance proteins in human urinary exosomes using peptide ligand library technology, peptide OFFGEL fractionation and nanoHPLC-chip-MS/MS.
Zhang Y; Li Y; Qiu F; Qiu Z
Electrophoresis; 2010 Dec; 31(23-24):3797-807. PubMed ID: 21082674
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]